SAB Biotherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.

About SABS

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies.

CEO

Samuel J. Reich

CEOSamuel J. Reich

Employees

Employees63

Headquarters

Miami Beach, Florida

HeadquartersMiami Beach, Florida

Founded

2014

Founded2014

Employees

Employees63

SABS Key Statistics

Market cap

17.38M

Market cap17.38M

Price-Earnings ratio

-0.52

Price-Earnings ratio-0.52

Dividend yield

—

Dividend yield—

Average volume

91.90K

Average volume91.90K

High today

$2.10

High today$2.10

Low today

$1.84

Low today$1.84

Open price

$2.10

Open price$2.10

Volume

21.69K

Volume21.69K

52 Week high

$5.01

52 Week high$5.01

52 Week low

$1.00

52 Week low$1.00

People also own

Based on the portfolios of people who own SABS. This list is generated using Robinhood data, and it’s not a recommendation.